Development, Translation and Validation of Enhanced Asian Rome III Questionnaires for Diagnosis of Functional Bowel Diseases in Major Asian Languages: A Rome Foundation-Asian Neurogastroenterology and Motility Association Working Team Report
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ghoshal, Uday C. | - |
dc.contributor.author | Gwee, Kok-Ann | - |
dc.contributor.author | Chen, Minhu | - |
dc.contributor.author | Gong, Xiao R. | - |
dc.contributor.author | Pratap, Nitesh | - |
dc.contributor.author | Hou, Xiaohua | - |
dc.contributor.author | Syam, An F. | - |
dc.contributor.author | Abdullah, Murdani | - |
dc.contributor.author | Bak, Young-Tae | - |
dc.contributor.author | Choi, Myung-Gyu | - |
dc.contributor.author | Gonlachanvit, Sutep | - |
dc.contributor.author | Chua, Andrew S. B. | - |
dc.contributor.author | Chong, Kuck-Meng | - |
dc.contributor.author | Siah, Kewin T. H. | - |
dc.contributor.author | Lu, Ching-Liang | - |
dc.contributor.author | Xiong, Lishou | - |
dc.contributor.author | Whitehead, William E. | - |
dc.date.accessioned | 2021-09-04T20:30:22Z | - |
dc.date.available | 2021-09-04T20:30:22Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2015-01 | - |
dc.identifier.issn | 2093-0879 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/94789 | - |
dc.description.abstract | Background/Aims The development-processes by regional socio-cultural adaptation of an Enhanced Asian Rome III questionnaire (EAR3Q), a cultural adaptation of the Rome III diagnostic questionnaire (R3DQ), and its translation-validation in Asian languages are presented. As English is not the first language for most Asians, translation-validation of EAR3Q is essential. Hence, we aimed to culturally adapt the R3DQ to develop EAR3Q and linguistically validate it to show that the EAR3Q is able to allocate diagnosis according to Rome III criteria. Methods After EAR3Q was developed by Asian experts by consensus, it was translated into Chinese, Hindi-Telugu, Indonesian, Korean, and Thai, following Rome Foundation guidelines; these were then validated on native subjects (healthy [n = 60], and patients with irritable bowel syndrome [n = 59], functional dyspepsia [n = 53] and functional constipation [n = 61]) diagnosed by clinicians using Rome III criteria, negative alarm features and investigations. Results Experts noted words for constipation, bloating, fullness and heartburn, posed difficulty. The English back-translated questionnaires demonstrated concordance with the original EAR3Q. Sensitivity and specificity of the questionnaires were high enough to diagnose respective functional gastrointestinal disorders (gold standard: clinical diagnoses) in most except Korean and Indonesian languages. Questionnaires often uncovered overlapping functional gastrointestinal disorders. Test-retest agreement (kappa) values of the translated questionnaires were high (0.700-1.000) except in Korean (0.300-0.500) and Indonesian (0.100-0.400) languages at the initial and 2-week follow-up visit. Conclusions Though Chinese, Hindi and Telugu translations were performed well: Korean and Indonesian versions were not. Questionnaires often uncovered overlapping FGIDs, which were quite common. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN SOC NEUROGASTROENTEROLOGY & MOTILITY | - |
dc.subject | CROSS-CULTURAL RESEARCH | - |
dc.subject | GASTROINTESTINAL DISORDERS | - |
dc.subject | DYSPEPSIA | - |
dc.subject | PREVALENCE | - |
dc.subject | SYMPTOMS | - |
dc.subject | POPULATION | - |
dc.subject | CRITERIA | - |
dc.subject | EPIDEMIOLOGY | - |
dc.subject | COMMUNITY | - |
dc.subject | COUNTRIES | - |
dc.title | Development, Translation and Validation of Enhanced Asian Rome III Questionnaires for Diagnosis of Functional Bowel Diseases in Major Asian Languages: A Rome Foundation-Asian Neurogastroenterology and Motility Association Working Team Report | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Bak, Young-Tae | - |
dc.identifier.doi | 10.5056/jnm14045 | - |
dc.identifier.scopusid | 2-s2.0-84920275364 | - |
dc.identifier.wosid | 000347736300010 | - |
dc.identifier.bibliographicCitation | JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, v.21, no.1, pp.83 - 92 | - |
dc.relation.isPartOf | JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY | - |
dc.citation.title | JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY | - |
dc.citation.volume | 21 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 83 | - |
dc.citation.endPage | 92 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001957721 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.subject.keywordPlus | CROSS-CULTURAL RESEARCH | - |
dc.subject.keywordPlus | GASTROINTESTINAL DISORDERS | - |
dc.subject.keywordPlus | DYSPEPSIA | - |
dc.subject.keywordPlus | PREVALENCE | - |
dc.subject.keywordPlus | SYMPTOMS | - |
dc.subject.keywordPlus | POPULATION | - |
dc.subject.keywordPlus | CRITERIA | - |
dc.subject.keywordPlus | EPIDEMIOLOGY | - |
dc.subject.keywordPlus | COMMUNITY | - |
dc.subject.keywordPlus | COUNTRIES | - |
dc.subject.keywordAuthor | Asia | - |
dc.subject.keywordAuthor | Gastrointestinal diseases | - |
dc.subject.keywordAuthor | Rome III criteria | - |
dc.subject.keywordAuthor | Translations | - |
dc.subject.keywordAuthor | Validation | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.